Barriers surround mpox vaccine access: 5 things to know

Becker's Healthcare November 5, 2024
Alexandra Murphy

As mpox cases rise globally, many Americans at high risk of contracting the virus are struggling to access the Jynneos vaccine due to its high cost and gaps in insurance coverage, The New York Times reported Nov. 4.

Here are five things to know:

1. While the vaccine was once available for free through federal programs, it is now commercially sold at nearly $300 per dose, creating barriers for uninsured individuals and vulnerable populations.
2. Insurance companies do not yet cover the vaccine or reimburse only a small fraction of the cost; that can leave many without access. People in high-risk groups, such as gay and bisexual men and those living with HIV, in...

Today's Sponsors

Today's Sponsor